{
    "2020-06-02": [
        [
            {
                "time": "2020-05",
                "original_text": "【招商策略】2020年5月陆股通持股分析——中美摩擦不改外资流入，加仓医药、科技和家电",
                "features": {
                    "keywords": [
                        "陆股通",
                        "中美摩擦",
                        "外资流入",
                        "医药",
                        "科技",
                        "家电"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技",
                        "家电"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2020-05",
                "original_text": "高瓴百亿重仓的“卖铲子”行业，干的是医药界富士康的生意？",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "重仓",
                        "医药",
                        "富士康"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05",
                "original_text": "医药生物行业点评报告：ASCO 2020全球进展解读：免疫疗法依旧亮眼，联合用药大势所趋",
                "features": {
                    "keywords": [
                        "医药生物",
                        "ASCO",
                        "免疫疗法",
                        "联合用药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2020-05",
                "original_text": "5月450亿减持创年度新高，科技医疗抛售居前",
                "features": {
                    "keywords": [
                        "减持",
                        "科技",
                        "医疗"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06",
                "original_text": "粤开医药6月谈：医药大分化下的结构性行情必然性",
                "features": {
                    "keywords": [
                        "粤开医药",
                        "大分化",
                        "结构性行情"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06",
                "original_text": "大消费盘前早知道：白酒行业淡季逆势涨价",
                "features": {
                    "keywords": [
                        "大消费",
                        "白酒",
                        "淡季涨价"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05",
                "original_text": "疫情期间IPO 这两家公司的底气何在？",
                "features": {
                    "keywords": [
                        "疫情期间",
                        "IPO",
                        "公司底气"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05",
                "original_text": "这只医药股1个月涨9倍，农夫山泉老板竟是医药界隐形富豪",
                "features": {
                    "keywords": [
                        "医药股",
                        "农夫山泉",
                        "隐形富豪"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05",
                "original_text": "医药生物行业投资策略月报：布局高景气度细分领域 聚焦业绩持续增长带来的机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "高景气度",
                        "业绩增长",
                        "投资策略"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            }
        ]
    ]
}